Syndrome  >>  pioglitazone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00521742: Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

Completed
3
300
US
Pioglitazone, Actos, AD4833, Glyburide
Takeda, Takeda Pharmaceuticals North America, Inc.
Diabetes Mellitus
01/03
01/03
NCT00521820: Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure

Terminated
3
518
US
Pioglitazone, Actos, AD-4833, Glyburide
Takeda
Diabetes Mellitus
10/03
10/03
NCT00331487: Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

Completed
3
719
US
Pioglitazone, Actos, AD4833, Rosiglitazone
Takeda, Eli Lilly and Company
Diabetes Mellitus
03/04
03/04
PROactive, NCT00174993: Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes

Completed
3
4373
Europe
Pioglitazone, Actos, AD4833, Placebo
Takeda, Eli Lilly and Company
Diabetes Mellitus
01/05
01/05
NCT00286494 / 2005-004669-40: Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Completed
3
493
US, Europe, RoW
Alogliptin and pioglitazone, SYR110322, Alogliptin, AD-4833, Pioglitazone, Actos, SYR-322
Takeda
Diabetes Mellitus
08/07
08/07
NCT00395512 / 2006-005492-17: Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus

Completed
3
655
US, Europe, RoW
Alogliptin, SYR-322, Pioglitazone, Actos, AD4833, Placebo
Takeda
Diabetes Mellitus
02/08
02/08
PRISMA, NCT00772174 / 2006-000725-54: Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

Completed
3
418
Europe
Pioglitazone and Metformin, ACTOS®, AD4833, Metformin
Takeda
Diabetes Mellitus
02/08
02/08
NCT00770952 / 2006-002271-41: Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.

Completed
3
91
Europe
Pioglitazone and Glimepiride, ACTOS®, Glimepiride
Takeda
Diabetes Mellitus
12/08
12/08
NCT00655863 / 2007-000486-38: Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.

Checkmark
Jan 2014 - Jan 2014: 
Checkmark P3 data
Jan 2012 - Jan 2012: P3 data
Checkmark P3 data
More
Completed
3
71
Europe
Alogliptin and Pioglitazone, alogliptin, SYR110322, Actos, AD-4833, SYR-322, Alogliptin, Placebo
Takeda
Diabetes Mellitus
12/09
12/09

Download Options